Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

March 10, 2022

An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]

Mays Cancer Center studies help spur leukemia drug’s approval

March 3, 2022

The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]

Cancer Patient with Cap Photo

Yahoo! News: Jill Biden meets cancer survivors, military families during Texas trip

February 24, 2022

During a visit to the Mays Cancer Center, Biden spoke to patients and doctors about the disparities of cancer care among Latinos. The Biden administration, along with the first lady, have advocated for jumpstarting cancer screenings that were missed or delayed due to the COVID-19 pandemic and ensure that tools to detect and treat cancer […]